Express News | Imagenebio Appoints Matt Robbins as General Counsel
Press Release: ImageneBio Appoints Matt Robbins as General Counsel
ImageneBio Shareholders Back Directors and Governance Proposals
ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
Wedbush Maintains ImageneBio(IMA.US) With Sell Rating, Maintains Target Price $2
Analysts Offer Insights on Healthcare Companies: ImageneBio (IMA) and Capricor Therapeutics (CAPR)
Wedbush Reiterates Underperform on ImageneBio, Maintains $2 Price Target
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/8/26?
Leerink Partners Maintains ImageneBio(IMA.US) With Buy Rating, Cuts Target Price to $24
William Blair Maintains ImageneBio(IMA.US) With Buy Rating
ImageneBio Q1 EPS $(0.95) Misses $(0.70) Estimate
ImageneBio | 10-Q: Quarterly report
ImageneBio | 8-K: ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
Express News | Imagenebio Reports First Quarter 2026 Financial Results and Provides Img-007 Program Update
ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/5/26?
Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/28/26?
Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/27/26?
12 Health Care Stocks Moving In Monday's After-Market Session
ImageneBio $30 Million Private Placement Ignites Stock